GB9520584D0 - Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same - Google Patents

Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Info

Publication number
GB9520584D0
GB9520584D0 GBGB9520584.5A GB9520584A GB9520584D0 GB 9520584 D0 GB9520584 D0 GB 9520584D0 GB 9520584 A GB9520584 A GB 9520584A GB 9520584 D0 GB9520584 D0 GB 9520584D0
Authority
GB
United Kingdom
Prior art keywords
processes
preparation
same
pharmaceutical composition
pyrazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9520584.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GBGB9520584.5A priority Critical patent/GB9520584D0/en
Publication of GB9520584D0 publication Critical patent/GB9520584D0/en
Priority to ZA968286A priority patent/ZA968286B/xx
Priority to CN96198649A priority patent/CN1203589A/zh
Priority to CA002234511A priority patent/CA2234511A1/fr
Priority to PCT/JP1996/002919 priority patent/WO1997013755A1/fr
Priority to EP96932841A priority patent/EP0856000A1/fr
Priority to JP9514909A priority patent/JPH11513403A/ja
Priority to KR1019980702464A priority patent/KR19990063989A/ko
Priority to AU71461/96A priority patent/AU7146196A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9520584.5A 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same Pending GB9520584D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9520584.5A GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ZA968286A ZA968286B (en) 1995-10-09 1996-10-02 Novel compounds
CN96198649A CN1203589A (zh) 1995-10-09 1996-10-08 新的化合物
CA002234511A CA2234511A1 (fr) 1995-10-09 1996-10-08 Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations
PCT/JP1996/002919 WO1997013755A1 (fr) 1995-10-09 1996-10-08 Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations
EP96932841A EP0856000A1 (fr) 1995-10-09 1996-10-08 Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations
JP9514909A JPH11513403A (ja) 1995-10-09 1996-10-08 炎症の治療に用いる１，３，５−三置換ピラゾール化合物
KR1019980702464A KR19990063989A (ko) 1995-10-09 1996-10-08 염증 치료용의 1,3,5-삼치환된 피라졸 화합물
AU71461/96A AU7146196A (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazoles for treament of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9520584.5A GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
GB9520584D0 true GB9520584D0 (en) 1995-12-13

Family

ID=10782007

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9520584.5A Pending GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Country Status (9)

Country Link
EP (1) EP0856000A1 (fr)
JP (1) JPH11513403A (fr)
KR (1) KR19990063989A (fr)
CN (1) CN1203589A (fr)
AU (1) AU7146196A (fr)
CA (1) CA2234511A1 (fr)
GB (1) GB9520584D0 (fr)
WO (1) WO1997013755A1 (fr)
ZA (1) ZA968286B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA68348C2 (en) * 1997-04-18 2004-08-16 Searle & Co Use of cyclooxygenase-2 inhibitors in preventing cardiovascular disorders
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
AUPO941497A0 (en) * 1997-09-24 1997-10-16 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
AUPP042397A0 (en) * 1997-11-18 1997-12-11 Fujisawa Pharmaceutical Co., Ltd. 5-arylpyrazole compounds
NZ333399A (en) 1997-12-24 2000-05-26 Sankyo Co Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
WO2000018741A2 (fr) * 1998-09-30 2000-04-06 Fujisawa Pharmaceutical Co., Ltd. Nouveaux composes
CA2379421A1 (fr) * 1999-08-27 2001-03-08 Abbott Laboratories Composes sulfonylphenylpyrazoles utiles en tant qu'inhibiteurs de cox-2
EP1104759B1 (fr) 1999-12-03 2003-10-22 Pfizer Products Inc. Composés hétéroarylphénylpyrazoles comme agents analgésiques et anti-inflammatoires
BR0016031A (pt) 1999-12-03 2002-07-23 Pfizer Prod Inc Derivados de heterociclo-alquilsulfonil pirazol como agentes antiinflamatórios/analgésicos
EP1104758B1 (fr) 1999-12-03 2003-07-23 Pfizer Products Inc. Dérives acétylènes anti-inflammatoires et/ou analgésiques
ES2193921T3 (es) 1999-12-03 2003-11-16 Pfizer Prod Inc Compuestos de sulfamoilheteroaril-pirazol como agentes antinflamatorios/analgesicos.
EP1273582B1 (fr) 2001-07-05 2005-06-29 Pfizer Products Inc. Pyrazoles heterocycliques alkylsulfoniques comme agents anti-inflammatoires/analgésiques
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
GT200200183A (es) 2001-09-28 2003-05-23 Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol
WO2003037336A1 (fr) 2001-11-02 2003-05-08 Pfizer Products Inc. Derives de 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile et autres composes utilises en tant qu'inhibiteurs de la cyclooxygenase dans le traitement de l'arthrite, de la neurodegeneration et du cancer du colon
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
JP2006511606A (ja) 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−２−δリガンド
ES2257929B1 (es) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos.
RS51940B (en) 2006-12-22 2012-02-29 Recordati Ireland Limited Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS
JP6151358B2 (ja) * 2012-07-30 2017-06-21 ザ オハイオ ステイト ユニバーシティ 抗菌性プロテインキナーゼインヒビター
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
NZ336428A (en) * 1993-11-30 2005-02-25 G use of substituted pyrazolyl benzosulphonamides to treat inflammation
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
AU3815495A (en) * 1994-11-08 1996-05-31 Eisai Co. Ltd. Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects

Also Published As

Publication number Publication date
CN1203589A (zh) 1998-12-30
WO1997013755A1 (fr) 1997-04-17
ZA968286B (en) 1997-05-13
JPH11513403A (ja) 1999-11-16
AU7146196A (en) 1997-04-30
CA2234511A1 (fr) 1997-04-17
EP0856000A1 (fr) 1998-08-05
KR19990063989A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
GB9520584D0 (en) Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL102946A0 (en) Pyrazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP9602122A2 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU7640696A (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
HUP9601176A3 (en) Amidine derivatives having adhesion-receptor antagonistic effect, pharmaceutical compositions containing the same and process for their preparation
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
GB9123353D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL104471A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same